Arkolith/Insider Trading/BLSM/Form 4

Li Yishan

Executive Chairman, Director, 10% OwnerBlossomHill Therapeutics, Inc. (BLSM) · full profile →Form 4 · filed Aug 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2026Conversion(C)113K——1.7M
Aug 10, 2026Conversion(C)125K——125K
Aug 10, 2026Conversion(C)1.6M——1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2026Conversion(C)125K——0
Aug 10, 2026Conversion(C)1.6M——0
Aug 10, 2026Conversion(C)113K——0
Aug 6, 2026Grant(A)113K—$0113K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001772233-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BlossomHill Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp